Table 4 Anticancer activity of HA against three cancer cell lines

500

57.40± 1.96^e

63.33±2.41^d

27.83±6.93^d

250

64.69± 1.21^d

64.59±1.66^d

58.00±2.63^c

125

74.58± 5.21^cd

72.52±1.85^c

75.33±3.74^b

62.5

74.69± 7.25^c

73.19±2.11^c

77.83±4.11^b

31.25

76.88± 3.96^c

76.67±3.33^bc

77.83±3.62^b

15.63

80.52± 5.24^bc

81.85±1.17^b

78.33±2.22^b

7.81

89.69± 1.62^b

93.78±2.86^a

79.00±4.62^b

3.91

95.10 ±2.82^ab

99.63±3.10^a

79.33±3.85^b

1.95

98.33 ±1.66^a

100±5.23^a

84.17±2.71^b

0.98

99.48 ±2.17^a

100±3.62^a

98.33±2.46^a

0.49

100±1.29^a

100±4.22^a

100±3.82^a

0.24

100±2.33^a

100±2.63^a

100±6.23^a

IC₅₀ (µg mL^-1)

1538.06

1209.21

273.40